Myeloablative vs non-myeloablative conditioning with allogeneic stem cell transplantation for high risk now Hodgkin's lymphoma: Similar outcomes despite differences in disease risk

被引:0
|
作者
Hewitt, M [1 ]
Porter, DL [1 ]
Hummel, K [1 ]
McAlee, A [1 ]
Phillips, J [1 ]
Stadtmauer, E [1 ]
Schuster, S [1 ]
Luger, S [1 ]
Nasta, S [1 ]
Tsai, D [1 ]
Loren, A [1 ]
Perl, A [1 ]
Emerson, S [1 ]
Goldstein, SC [1 ]
机构
[1] Univ Penn, Blood & Marrow Stem Cell Transplant Program, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/j.bbmt.2004.12.079
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
79
引用
收藏
页码:27 / 28
页数:2
相关论文
共 50 条
  • [31] Early and late gastrointestinal complications after allogeneic stem cell transplantation following myeloablative and non-myeloablative conditioning.
    Schulenburg, A
    Turetschek, K
    Wrba, F
    Vogelsang, H
    Greinix, HT
    Keil, F
    Mitterbauer, M
    Kalhs, P
    BLOOD, 2002, 100 (11) : 631A - 631A
  • [32] Progressive disease after non-myeloablative allogeneic stem cell transplantation.
    Bolwell, BJ
    Pohlman, B
    Sobecks, R
    Andresen, S
    Theil, KS
    Brown, S
    Bernhard, L
    Curtis, J
    Koennecke, J
    Kosar, J
    Ostendorf, H
    Sands, K
    Serafin, M
    Kalaycio, M
    BLOOD, 2002, 100 (11) : 634A - 634A
  • [33] Improved disease free survival following non-myeloablative allogeneic stem cell transplantation compared with autologous transplantation in poor risk follicular lymphoma
    Ingram, W
    Devereux, S
    Gonzalez, J
    Ho, A
    Mufti, GJ
    Pagliuca, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 110 - 111
  • [34] Allogeneic stem cell transplantation after non-myeloablative preparative regimen in primary refractory Hodgkin's Disease (HD)
    Lentini, G
    Willenbacher, W
    Günzelmann, S
    Roemer, E
    Basara, N
    Fauser, AA
    Kiehl, MG
    BONE MARROW TRANSPLANTATION, 2001, 27 : S290 - S290
  • [35] Non-myeloablative conditioning regimen in Allogeneic Peripheral Blood Stem Cell Transplantation (AlloPBSCT) for high-risk Hematologic Malignancies (HM)
    Vaz, CP
    Campilho, F
    Campos, A
    Carvalhais, A
    Roncon, S
    Martinho, A
    Duarte, R
    Raimundo, A
    Avila, A
    Pimentel, P
    BONE MARROW TRANSPLANTATION, 2001, 27 : S293 - S293
  • [36] NON MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH HIGH RISK LYMPHOMA: A SINGLE CENTRE EXPERIENCE
    Console, G.
    Messina, G.
    Martino, M.
    Irrera, G.
    Pucci, G.
    Moscato, T.
    Fedele, R.
    Massara, E.
    Cuzzola, M.
    Gatto, F.
    Spiniello, E.
    Meliado, A.
    Rigolino, C.
    Dattola, A.
    Gareffa, C.
    Callea, I
    Pontari, A.
    Monteleone, R.
    Stelitano, C.
    Callea, V
    Mamone, D.
    Kropp, M. G.
    Molica, S.
    Vigliotti, M. L.
    Iacopino, P.
    HAEMATOLOGICA, 2008, 93 : S102 - S102
  • [37] Incidence and outcome of thrombotic microangiopathy after allogeneic peripheral blood stem cell transplantation with non-myeloablative conditioning compared with myeloablative conditioning
    Willems, E
    Baron, F
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2006, 37 : S46 - S46
  • [38] Allogenic stem cell transplantation after non-myeloablative conditioning regimen ("mini-allogeneic" stem cell transplantation)
    Milpied, N
    PATHOLOGIE BIOLOGIE, 2002, 50 (01): : 42 - 44
  • [39] Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection
    B J Byrne
    M Horwitz
    G D Long
    C Gasparetto
    K M Sullivan
    J Chute
    N J Chao
    D A Rizzieri
    Bone Marrow Transplantation, 2008, 41 : 39 - 43
  • [40] Allogeneic stem cell transplantation using non-myeloablative conditioning regimens: Results of the Mexican approach
    Guillermo J. Ruiz-Argüelles
    International Journal of Hematology, 2002, 76 : 376 - 379